An inspiring month for those of us working to support the needs of patients with #IgANephropathy (#IgAN)! Read what members of the community have shared about the recently published KDIGO guideline update for IgA Nephropathy. Learn more: https://lnkd.in/eUPy4kGJ
Vera Therapeutics, Inc.
Biotechnology Research
Brisbane, California 19,854 followers
We are a clinical-stage biotechnology company developing treatments that transform patients’ lives.
About us
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for serious immunological diseases to improve patients’ lives. Fraud alert for potential candidates for positions at Vera: your personal information and online safety are a top priority for us. At Vera Therapeutics, recruiters will only direct candidates to apply through our official career page at https://veratx.com/careers/. We will never request payments, ask for financial account information or sensitive information such as social security numbers. If you are unsure if a message is from Vera Therapeutics, please email hr@veratx.com.
- Website
-
http://www.veratx.com
External link for Vera Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Brisbane, California
- Type
- Public Company
Locations
-
Primary
2000 Sierra Point Pkwy
1200
Brisbane, California 94005, US
Employees at Vera Therapeutics, Inc.
Updates
-
The updated KDIGO guidelines for #IgANephropathy (#IgAN) mark a major step forward for patients and clinicians. For the first time, the guidelines recommend simultaneously: 1. initiating therapies that target IgAN-specific disease drivers, and 2. managing the consequences of IgAN-induced nephron loss in patients at risk of progression. An approach that aims to stop the synthesis of pathogenic forms of IgA and IgA-immune complex formation is recommended as part of the strategy to meet the treatment goal of minimizing the rate of kidney function loss to <1 mL/min/year. We’re energized by the continuing progress recognized by KDIGO and we look forward to future updates as the treatment landscape evolves. Read more about the KDIGO update: https://lnkd.in/eUPy4kGJ
-
Team Vera is at the 18th International Symposium on #IgANephropathy in Prague! Visit us at booth 2 and don’t miss our sponsored breakfast symposium on Friday Sep 19, 7:55 – 8:55 am CEST: Controversies in IgA Nephropathy: A Panel Discussion. #IgAN
-
-
We're looking forward to connecting with nephrologists and discussing the latest research in #IgAN at the 18th International Symposium on #IgANephropathy next week in Prague. Join us at our sponsored breakfast symposium on Friday Sep 19, 7:55 – 8:55 am CEST: Controversies in IgA Nephropathy: A Panel Discussion. Also, be sure to visit us at booth #2!
-
Vera Therapeutics is proud to join the Living Donor Circle of Excellence, an initiative from the American Society of Transplantation that celebrates employers who provide salary support to employees who choose to be a living organ donor. We were honored to support the Living Donor Circle of Excellence reception at the World Transplant Congress 2025. Our commitment to patients goes beyond our mission to develop transformative treatments. Empathy for patients, our employees, and all our other stakeholders extends beyond our daily work and is a part of who we are as a company. We’re proud to be a part of this crucial program. Learn more about the Living Donor Circle of Excellence: www.LivingDonorCircle.com
-
-
Our headquarters building in Brisbane, CA now displays the Vera logo! We're thrilled that the outside of the building now represents the talented and dynamic team within our offices and across the country, all working together to advance transformative treatments for patients with serious immunologic diseases.
-
We’re attending the Morgan Stanley 23rd Annual Global Healthcare Conference in New York next week. Join us for a fireside chat on Monday September 8 at 5:35pm ET: https://lnkd.in/exkF_-D6 $VERA
-
-
We're attending the Cantor Global Healthcare Conference in New York next week. Join us for a fireside chat on Thursday September 4 at 9:10 am ET: https://lnkd.in/exSjhgTb $VERA
-
-
Today we provided a business update and reported Q2 financial results. Read the press release here: https://lnkd.in/eG9rUe9x $VERA
-